EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
Authors:
- Maksim Sergeyevna EliseevMEMaksim Sergeyevna Eliseev
- O V ZhelyabinOZO V Zhelyabin
- V G BarskovaVBV G Barskova
- E L NasonovENE L Nasonov
- 26 March 2014
- journal article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 52 (1) , 99-101